Boston Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.24M | Buy |
61,106
+23,179
| +61% | +$470K | 0.06% | 354 |
|
|
2019
Q2 | $838K | Sell |
37,927
-21,238
| -36% | -$469K | 0.04% | 397 |
|
|
2019
Q1 | $807K | Buy |
59,165
+26,105
| +79% | +$356K | 0.04% | 381 |
|
|
2018
Q4 | $299K | Buy |
33,060
+3,725
| +13% | +$33.7K | 0.02% | 536 |
|
|
2018
Q3 | $484K | Sell |
29,335
-180
| -0.6% | -$2.97K | 0.02% | 485 |
|
|
2018
Q2 | $413K | Buy |
+29,515
| New | +$413K | 0.01% | 527 |
|
|
2017
Q3 | – | Sell |
-16,995
| Closed | -$244K | – | 647 |
|
|
2017
Q2 | $244K | Buy |
+16,995
| New | +$244K | 0.01% | 607 |
|